ADC Therapeutics (ADCT) Interest Coverage Ratio (2020 - 2026)
ADC Therapeutics (ADCT) posted quarterly Interest Coverage Ratio of 2.04 for Q1 2026, up 12.16% year-on-year from 1.82 in Q1 2025, and up 11.6% on a QoQ basis from 2.31 in Q3 2025.
ADC Therapeutics (ADCT) Interest Coverage Ratio (2020 - 2026) Analysis & Trends
ADC Therapeutics (ADCT) has reported Interest Coverage Ratio for 7 consecutive years, with 2.04 the latest figure, recorded in Q1 2026.
- Quarterly Interest Coverage Ratio rose 12.16% year-over-year to 2.04 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 8.83 (down 248.21% YoY) and the FY2022 annual result came in at 0.16, up 98.59% from the prior year.
- Interest Coverage Ratio advanced to 2.04 in Q1 2026 per ADCT's latest filing, from 2.31 in the prior quarter.
- Over the last five years, Interest Coverage Ratio for ADCT reached as high as 0.27 in Q3 2022 and fell as low as 7.89 in Q2 2022.
- A 5-year average of 3.32 and a median of 2.77 in 2023 frame the typical range for Interest Coverage Ratio.
- Annual changes were most pronounced in 2022 — Interest Coverage Ratio jumped 97.98% — and 2023, when it tumbled 928.61%.
- Year by year, Interest Coverage Ratio stood at 4.58 in 2022, then surged by 38.4% to 2.82 in 2023, then increased by 3.88% to 2.71 in 2024, then rose by 14.71% to 2.31 in 2025, then climbed by 11.6% to 2.04 in 2026.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 2.04, 2.31, and 3.4 for Q1 2026, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | ADC Therapeutics | 189.60 Mn | -41.41 Mn | 17.38 Mn | -2.04 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.04 |
| Sep 30, 2025 | -2.31 |
| Jun 30, 2025 | -3.40 |
| Mar 31, 2025 | -2.33 |
| Sep 30, 2024 | -2.71 |
| Jun 30, 2024 | -2.29 |
| Mar 31, 2024 | -2.69 |
| Sep 30, 2023 | -2.82 |
| Jun 30, 2023 | -3.85 |
| Mar 31, 2023 | -4.95 |
| Dec 31, 2022 | -4.58 |
| Sep 30, 2022 | -0.27 |
| Jun 30, 2022 | -7.89 |
| Mar 31, 2022 | -4.38 |
| Dec 31, 2021 | -2.73 |
| Sep 30, 2021 | -13.55 |
| Jun 30, 2021 | -27.59 |
| Mar 31, 2021 | -31.85 |
| Dec 31, 2020 | -26.48 |
| Sep 30, 2020 | -27.02 |